Lv41
790 积分 2025-09-26 加入
Unlocking the potential of bispecific ADCs for targeted cancer therapy
1个月前
已完结
The global patent landscape of bispecific antibodies: technological innovations and therapeutic applications
3个月前
已完结
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
3个月前
已完结
An Update on Patent issues regarding Antibody Drug Conjugates
5个月前
已完结
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
7个月前
已完结
体内嵌合抗原受体T细胞（in vivo CAR-T）研究进展及非临床研究一般考虑
8个月前
已完结
What will be the first AI-designed drug? These disease-fighting antibodies are top contenders
9个月前
已完结
The present and future of bispecific antibodies for cancer therapy
10个月前
已完结
Linker Design for the Antibody Drug Conjugates: A Comprehensive Review
10个月前
已完结
In vivo CAR-Ts captivate big pharma
10个月前
已完结
皖公网安备34019202002308
